BSE filing, NSE: SYNCOMF. Summary written from the filing by ALFA Finder's alert engine.
Syncom Formulation (India) Ltd: key numbers
- Share price
- ₹20.33
- Market cap
- ₹1,911 Cr
- Revenue (annual)
- ₹489.2 Cr
- Net profit (annual)
- ₹76.44 Cr
- P/E (TTM)
- 22.3×Sector 46.1×
- Promoter holding
- 50.57%+0.00% QoQ
- FII holding
- 2.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syncom Formulation (India) Ltd
All →Syncom Formulation (India) Other Announcement
Syncom Formulations (India) Limited filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Syncom Formulation (India) Dividend
Syncom Formulations (India) Ltd shareholders approved a final dividend of Rs. 0.10 per equity share at the 38th AGM, totaling Rs. 9.40 Crore.
- Value
- ₹9.40 Cr
Syncom Formulation (India) Annual General Meeting
Syncom Formulations (India) Limited held its 38th Annual General Meeting on September 30, 2026, via video conferencing to transact various ordinary and special business items.
Syncom Formulation (India) Other Announcement
Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.
- Value
- ₹4.75 Cr
Syncom Formulation (India) Other Announcement
Syncom Formulations fixed 23 Sep 2026 as record date for a proposed 10% dividend (Rs.0.10/share) pending AGM approval. The 38th AGM is scheduled for 30 Sep 2026.
Syncom Formulation (India) Other Announcement
Syncom Formulations (India) Limited informed exchanges about the dispatch of letters to shareholders with unregistered email addresses, providing instructions to access the 38th AGM Notice and Annual Report.
Other management change announcements
All →Raymond Realty Management Change
Raymond Realty said joint statutory auditor Chaturvedi & Shah LLP resigned on 28 October 2026 after a dispute over audit fee revision. Walker Chandiok & Co LLP continues as the other statutory auditor.
Aarti Pharmalabs Management Change
Aarti Pharmalabs accepted CFO Piyush Lakhani's resignation, effective 30 October 2026, and appointed Vibha Thakker as CFO from 31 October 2026. The filing records a senior management change with no monetary amount.
TruCap Finance Management Change
TruCap Finance designated three employees as Senior Management Personnel, effective 29 October 2026. The changes are additional charges for Product, Operations and Contact Centre roles.
Sayaji Hotels (Indore) Management Change
Sayaji Hotels (Indore) appointed Azhar Yusuf Dhanani as Additional Non-Executive Non-Independent Director effective October 28, 2026. Shareholder approval is required within three months.
Fabtech Technologies Management Change
FABTECH Technologies appointed Mr. Alan Dias as Vice President - HR, a senior management personnel role, effective October 28, 2026. He brings over 24 years of human resources experience.
Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.